Sort   by:  
 Page size 
Even though gefitinib, a tyrosine kinase inhibitor, widely used in treating non-small cell lung cancer (NSCLC) patients carrying EGFR activating mutations, most patients will develop gefitinib resistance. Protein ubiquitylation is one of major posttranslational modifications affecting the stab...
ORGANISM(S): Homo sapiens (Human) 
2018-07-05 | PXD004941 | Pride
Cell membrane protein-protein interactions (PPIs) play pivotal roles in maintaining cellular homeostasis and physiological balance. Deciphering these interactions is crucial for understanding disease mechanisms and identifying therapeutic targets. While proximity labeling technologies have revolutio...
ORGANISM(S): Homo Sapiens 
2026-02-27 | PXD074981 |
Sort   by:  
 Page size